Arun Sharma, MD, MS
Areas of Expertise and Research Interests:
- Head and neck cancer
- Thyroid cancer
- Transoral robotic surgery (TORS)
- Head and neck cancer disparities
- Quality of life and functional outcomes
Dr. Arun Sharma is Assistant Professor in the Division of Otolaryngology-Head and Neck Surgery. Dr. Sharma is a head and neck surgical oncologist who specializes in the treatment of head and neck cancer, skin cancer of the head and neck, thyroid and parathyroid neoplasms, and salivary gland neoplasms. He has advanced training in minimally invasive approaches to the head and neck, including transoral robotic surgery (TORS), transoral laser microsurgery (TLM) for laryngeal lesions and cancers, and minimally invasive video-assisted thyroidectomy (MIVAT).
Dr. Sharma attended college at Johns Hopkins University in Baltimore, Maryland. He received his medical degree and Master’s in clinical research at the University of Pittsburgh School of Medicine. He completed his otolaryngology-head and neck surgery residency at the University of Washington in Seattle and a fellowship in advanced oncologic head and neck surgery at the University of Pittsburgh Medical Center.
Dr. Sharma’s research is focused on understanding factors that affect head and neck cancer outcomes, with the eventual goal to implement interventions to improve outcomes. This include ongoing work on rural-urban disparities and quality of life in head and neck cancer.
He is a member of the American Head & Neck Society (AHNS) and American Academy of Otolaryngology - Head & Neck Surgery (AAO-HNS). He has served on multiple committee with the AHNS and AAO-HNS.
Watch Dr. Sharma talk about Head and Neck Cancer Care
Watch Dr. Sharma talk about Robotic Surgery
Collaborative Cancer Disparities Research Program (CCDRP), Southern Illinois University School of Medicine - Siteman Cancer Center, 9/16-8/17, “Assessing Head and Neck Cancer Awareness as a Function of Rural Residence”, Principal Investigator, $50,000.
SIU Team Scientist Grant (TSG), Southern Illinois University School of Medicine – Simmons Cancer Institute, 7/16-7/18, “Epstein-Barr Virus (EBV)-specific humoral responses in EBV-related and -unrelated malignancies”. Co-Investigator, $99,688.00.